Insider Trading activities at Semnur Pharmaceuticals, Inc. (SMNR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Semnur Pharmaceuticals, Inc. (SMNR) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Semnur Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1913577.

Total stock buying since 2022: $10,200,000.
Total stock sales since 2022: $200,000,000.
Total stock option exercises since 2022: $0.


3 insiders reported insider trading activities at Semnur Pharmaceuticals, Inc. (SMNR):
Insider trading activities of Xu Jiandong
Insider trading activities of Scilex, Inc.
Insider trading activities of Denali Capital Global Investments Llc

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Semnur Pharmaceuticals, Inc. (SMNR).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 12,500,000 $200,000,000 0 $0
2022 1,020,000 $10,200,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Semnur Pharmaceuticals, Inc. (SMNR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-09 0 $0 12,500,000 $200,000,000 0 $0
2022-04 1,020,000 $10,200,000 0 $0 0 $0

Table 3. Detailed insider trading at Semnur Pharmaceuticals, Inc. (SMNR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-09-23 Scilex, Inc. Sale 12,500,000 16.00 200,000,000
2022-04-11 Denali Capital Global Investments Llc Buy 510,000 10.00 5,100,000
2022-04-11 Xu Jiandong Buy 510,000 10.00 5,100,000

Insider trading activities including stock purchases, stock sales, and option exercises of SMNR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Semnur Pharmaceuticals, Inc. (symbol SMNR, CIK number 1913577) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.